Stem Cells International
Volume 2010 (2010), Article ID 431909, 4 pages
doi:10.4061/2010/431909
Case Report

Enhanced Engraftment of a Very Low-Dose Cord Blood Unit in an Adult Haemopoietic Transplant by Addition of Six Mismatched Viable Cord Units

Stephen J. Proctor,1 Catherine E. Chapman,2 Rachel Sharples,3 Helen L. Lucraft,4 Jennifer Wilkinson,1 Jane Conn,3 and Peter G. Middleton1

1Haematological oncology Group, Academic Haematology, Medical School, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
2Medical Department, Newcastle Blood Centre, NHS Blood and Transplant, Holland Drive, Newcastle upon Tyne NE2 4NQ, UK
3Newcastle NHS Hospital Foundation Trust, Freeman Road, Newcastle upon Tyne NE7 7DN, UK
4Northern Centre for Cancer Treatment, Newcastle NHS Hospital Foundation Trust, Freeman Road, Newcastle upon Tyne, NE7 7DN, UK

Received 3 March 2009; Revised 25 June 2009; Accepted 5 August 2009

Academic Editor: Amin Rahemtulla

Copyright © 2010 Stephen J. Proctor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. N. Barker, D. J. Weisdorf, and J. E. Wagner, “Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors,” The New England Journal of Medicine, vol. 344, no. 24, pp. 1870–1871, 2001. View at Publisher · View at Google Scholar
  2. J. N. Barker, D. J. Weisdorf, T. E. DeFor, et al., “Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy,” Blood, vol. 105, no. 3, pp. 1343–1347, 2005. View at Publisher · View at Google Scholar · View at PubMed
  3. C. G. Brunstein and J. E. Wagner, “Cord blood transplantation for adults,” Vox Sanguinis, vol. 91, no. 3, pp. 195–205, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. J. E. Wagner, J. N. Barker, T. E. DeFor, et al., “Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD 34 cell dose and HLA disparity on treatment-related mortality and survival,” Blood, vol. 100, no. 5, pp. 1611–1618, 2002. View at Publisher · View at Google Scholar · View at PubMed
  5. E. Gluckman and V. Rocha, “Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis,” in Blood Cells, Molecules, and Diseases, vol. 33, no. 3, pp. 271–273, 2004. View at Publisher · View at Google Scholar · View at PubMed
  6. A. J. Nauta, A. B. Kruisselbrink, E. Lurvink, et al., “Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit,” Experimental Hematology, vol. 33, no. 10, pp. 1249–1256, 2005. View at Publisher · View at Google Scholar · View at PubMed
  7. J. Gryn, D. T. Harris, R. K. Shadduck, et al., “Multiple unmatched umbilical cord units (MUCs) for adult allogeneic transplantation,” Blood, vol. 98, no. 11, p. 666a, 2001.
  8. J. Lister, J. F. Gryn, K. L. McQueen, D. T. Harris, J. M. Rossetti, and R. K. Shadduck, “Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy,” Stem Cells and Development, vol. 16, no. 1, pp. 177–186, 2007. View at Publisher · View at Google Scholar · View at PubMed
  9. L. He, L. Luo, S. J. Proctor, et al., “Somatic mitochondrial DNA mutations in adult-onset leukaemia,” Leukemia, vol. 17, no. 12, pp. 2487–2491, 2003. View at Publisher · View at Google Scholar · View at PubMed
  10. E. Gluckman, “Cord blood transplantation,” Biology of Blood and Marrow Transplantation, vol. 12, pp. 808–812, 2006.
  11. L. Lekakis, S. T. Giralt, D. Couriel, et al., “Phase II study of unrelated cord blood transplantation for adults with high risk haematologic malignancies,” Bone Marrow Transplant, vol. 38, no. 6, pp. 421–426, 2006.
  12. A. Bacigalupo, T. Lamparelli, F. Gualandi, et al., “Allogeneic haemopoetic stem cell transplants for patients with relapsed acute leukaemia; long term outcome,” Bone Marrow Transplant, vol. 39, no. 6, pp. 341–346, 2007.